{
    "organizations": [],
    "uuid": "d99d295389b344a705eb51df27ad2b076dba4978",
    "author": "",
    "url": "https://www.reuters.com/article/brief-omeros-reaches-agreement-with-fda/brief-omeros-reaches-agreement-with-fda-on-oms721-phase-3-trial-protocol-for-iga-nephropathy-idUSASB0BZJF",
    "ord_in_thread": 0,
    "title": "BRIEF-Omeros Reaches Agreement With FDA On OMS721 Phase 3 Trial Protocol For IgA Nephropathy",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 16 PM / in 8 minutes BRIEF-Omeros Reaches Agreement With FDA On OMS721 Phase 3 Trial Protocol For IgA Nephropathy Reuters Staff \nJan 3 (Reuters) - Omeros Corp: \n* OMEROS CORPORATION REACHES AGREEMENT WITH FDA ON OMS721 PHASE 3 TRIAL PROTOCOL FOR IGA NEPHROPATHY \n* OMEROS CORPORATION REACHES AGREEMENT WITH FDA ON OMS721 PHASE 3 TRIAL PROTOCOL FOR IGA NEPHROPATHY \n* OMEROS CORP - ‍INITIATES OMS721 PHASE 3 PROGRAM IN HCT-TMA​ \n* OMEROS CORP - ‍ PATIENT ENROLLMENT FOR ITS PHASE 3 CLINICAL TRIAL EVALUATING OMS721 IN PATIENTS WITH IGA NEPHROPATHY IS EXPECTED TO BEGIN EARLY IN FEB Source text for Eikon: Further company coverage:",
    "published": "2018-01-03T14:14:00.000+02:00",
    "crawled": "2018-01-03T14:28:54.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "minute",
        "reach",
        "agreement",
        "fda",
        "oms721",
        "phase",
        "trial",
        "protocol",
        "iga",
        "nephropathy",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "omeros",
        "corp",
        "omeros",
        "corporation",
        "reach",
        "agreement",
        "fda",
        "oms721",
        "phase",
        "trial",
        "protocol",
        "iga",
        "nephropathy",
        "omeros",
        "corporation",
        "reach",
        "agreement",
        "fda",
        "oms721",
        "phase",
        "trial",
        "protocol",
        "iga",
        "nephropathy",
        "omeros",
        "corp",
        "oms721",
        "phase",
        "program",
        "omeros",
        "corp",
        "patient",
        "enrollment",
        "phase",
        "clinical",
        "trial",
        "evaluating",
        "oms721",
        "patient",
        "iga",
        "nephropathy",
        "expected",
        "begin",
        "early",
        "feb",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}